Previous Close | 103.46 |
Open | 103.22 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1100 |
Day's Range | 102.48 - 103.79 |
52 Week Range | 72.88 - 115.49 |
Volume | |
Avg. Volume | 9,187,655 |
Market Cap | 260.994B |
Beta (5Y Monthly) | 0.33 |
PE Ratio (TTM) | 37.18 |
EPS (TTM) | 2.77 |
Earnings Date | Feb 02, 2023 |
Forward Dividend & Yield | 2.76 (2.82%) |
Ex-Dividend Date | Sept 14, 2022 |
1y Target Est | 104.59 |
Merck ( NYSE:MRK ) Full Year 2022 Results Key Financial Results Revenue: US$59.3b (up 22% from FY 2021). Net income...
AbbVie has put in a mixed earnings performance, exceeding bottom line estimates in five consecutive quarters but falling short of sales expectations in each instance.
Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.